Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice

Cited by (387)

Items 101–200 of 387

1. BCL6 as a therapeutic target for lymphoma
   Rebecca J. Leeman‐Neill, Govind Bhagat · 2017 · Expert Opinion on Therapeutic Targets
2. Spleen Tyrosine Kinase (Syk), a Novel Target of Curcumin, Is Required for B Lymphoma Growth
   Murali Gururajan, Trivikram Dasu, Seif Shahidain, C. DARRELL JENNINGS, Darrell A. Robertson, Vivek M. Rangnekar, Subbarao Bondada · 2007 · The Journal of Immunology
3. An Oncogenic Role for Alternative NF-κB Signaling in DLBCL Revealed upon Deregulated BCL6 Expression
   Baochun Zhang, Dinis Pedro Calado, Zhe Wang, Sebastian Fröhler, Karl Köchert, Qian Yu, Sergei B. Koralov, Marc Schmidt‐Supprian, Yoshiteru Sasaki, Christine Unitt et al. · 2015 · Cell Reports
4. Genetic lesions in diffuse large B-cell lymphomas
   Monica Testoni, Emanuele Zucca, Ken H. Young, Francesco Bertoni · 2015 · Annals of Oncology
5. AID-Induced Genotoxic Stress Promotes B Cell Differentiation in the Germinal Center via ATM and LKB1 Signaling
   Mara H. Sherman, Ali I. Kuraishy, Chetan Deshpande, Jason S. Hong, Nicholas A. Cacalano, Richard A. Gatti, John P. Manis, Michael A. Damore, Matteo A. Pellegrini, Michael A. Teitell · 2010 · Molecular Cell
6. T follicular helper cells and T follicular regulatory cells in autoimmune diseases
   Jingjing Qi, Chang Liu, Ziran Bai, Xia Li, Genhong Yao · 2023 · Frontiers in Immunology
7. Discovery of Pyrazolo[1,5-a]pyrimidine B-Cell Lymphoma 6 (BCL6) Binders and Optimization to High Affinity Macrocyclic Inhibitors
   William McCoull, Roman Abrams, Erica K. Anderson, Kevin Blades, Peter Barton, Matthew R. Box, Jonathan Burgess, Kate F. Byth, Qing Cao, Claudio E. Chuaqui et al. · 2017 · Journal of Medicinal Chemistry
8. BCL6 promotes glioma and serves as a therapeutic target
   Liang Xu, Ye Chen, Marina Dutra‐Clarke, Anand Mayakonda, Masaharu Hazawa, Steve E. Savinoff, Ngan Doan, JONATHAN W. SAID, William H. Yong, Ashley Watkins et al. · 2017 · Proceedings of the National Academy of Sciences
9. Molecular pathogenesis of germinal center‐derived B cell lymphomas
   Laura Pasqualucci · 2019 · Immunological Reviews
10. Murine Models of B-Cell Lymphomas: Promising Tools for Designing Cancer Therapies
    Sabrina Donnou, Claire Galand, Valérie Touitou, Catherine Sautès‐Fridman, Zsuzsanna Fábry, Sylvain Fisson · 2012 · Advances in Hematology
11. PRMT5 interacts with the BCL6 oncoprotein and is required for germinal center formation and lymphoma cell survival
    Xiaoqing Lu, Tharu M. Fernando, Chen Lossos, Nevin Yusufova, Fan Liu, Lorena Fontán, Matthew Durant, Huimin Geng, Jacob Melnick, Yuan Luo et al. · 2018 · Blood
12. Development of covalent inhibitors: Principle, design, and application in cancer
    Zheng, Lang, Li, Yang, Wu, Defa, Xiao, Huan, Zheng, Shilong, Wang, Guan, Sun, Qiu · 2023 · MedComm – Oncology
13. CtBP Is an Essential Corepressor for BCL6 Autoregulation
    Lourdes Mendez, Jose Maria Polo, Jinmei Yu, Melissa Krupski, B. Belinda Ding, Ari M. Melnick, B. Hilda Ye · 2008 · Molecular and Cellular Biology
14. The role of BCL6 in lymphomas and routes to therapy
    Simon D. Wagner, Matthew J. Ahearne, Paul Ko Ferrigno · 2010 · British Journal of Haematology
15. Lymphoma stem cells: enough evidence to support their existence?
    Jose Angel Martinez-Climent, Lorena Fontán, Randy D. Gascoyne, Reiner Siebert, Felipe Prósper · 2010 · Haematologica
16. The genetic basis of diffuse large B-cell lymphoma
    Laura Pasqualucci · 2013 · Current Opinion in Hematology
17. Advances in biology, diagnosis and treatment of DLBCL
    Yuanfei Shi, Yi Xin Xu, Huafei Shen, Jie Jin, Hongyan Tong, Wanzhuo Xie · 2024 · Annals of Hematology
18. High BCL6 expression predicts better prognosis, independent of BCL6 translocation status, translocation partner, or BCL6-deregulating mutations, in gastric lymphoma
    Yun-Wen Chen, Xiao-Tong Hu, Anthony C. T. Liang, Wing-Yan Au, C.C So, Michelle L. Y. Wong, Lijun Shen, Qian Tao, Kent‐Man Chu, Yok‐Lam Kwong et al. · 2006 · Blood
19. Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma
    Benedetta Apollonio, Filomena Spada, Nedyalko Petrov, Domenico Cozzetto, Despoina Papazoglou, Peter Jarvis, Shichina Kannambath, Manuela Terranova-Barberio, Rose‐Marie Amini, Gunilla Enblad et al. · 2023 · Journal of Clinical Investigation
20. Signatures of murine B-cell development implicate Yy1 as a regulator of the germinal center-specific program
    Michael R. Green, Stefano Monti, Riccardo Dalla‐Favera, Laura Pasqualucci, Nicole C. Walsh, Marc Schmidt‐Supprian, Jeffery Lorne Kutok, Scott J. Rodig, Donna S Neuberg, Klaus Rajewsky et al. · 2011 · Proceedings of the National Academy of Sciences
21. Requirement for cyclin D3 in germinal center formation and function
    Jonathan U. Peled, J. Jessica Yu, Venkatesh Jeganathan, Enguang Bi, B. Belinda Ding, Melissa Krupski, Rita Shaknovich, Piotr Siciński, Betty Diamond, Matthew D. Scharff et al. · 2010 · Cell Research
22. Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomas
    Reimann, Maurice, Schrezenmeier, Jens, Richter-Pechanska, Paulina, Dolnik, Anna, Hick, Timon Pablo, Schleich, Kolja, Cai, Xiurong, Fan, Dorothy N. Y., Lohneis, Philipp, Maßwig, Sven et al. · 2021 · Blood
23. miR-217 is an oncogene that enhances the germinal center reaction
    Virginia G. de Yébenes, Nahikari Bartolomé‐Izquierdo, Rubén Nogales‐Cadenas, Pablo Pérez‐Durán, Sonia M. Mur, Nerea Martı́nez, Lorena Di Lisio, Davide F. Robbiani, Alberto Pascual-Montano, Marta Cañamero et al. · 2014 · Blood
24. A Network Model to Describe the Terminal Differentiation of B Cells
    Akram Méndez, Luis Mendoza · 2016 · PLoS Computational Biology
25. Impairment of both IRE1 expression and XBP1 activation is a hallmark of GCB DLBCL and contributes to tumor growth
    Bojan Bujisic, Aude De Gassart, Rémy Tallant, Olivier Demaria, Léa Zaffalon, Sonia Tassadit Chelbi, Michel F. Gilliet, Francesco Bertoni, Fabio Martinon · 2017 · Blood
26. Pathogenetic and Clinical Implications of Non-Immunoglobulin; BCL6 Translocations in B-Cell Non-Hodgkin's Lymphoma
    Hitoshi Ohno · 2006 · Journal of the Japan Society of the Reticuloendothelial System
27. IL4 and IL21 cooperate to induce the high Bcl6 protein level required for germinal center formation
    Stéphane Chevrier, Tobias Kratina, Dianne Emslie, David Mathew Tarlinton, Lynn M. Corcoran · 2017 · Immunology and Cell Biology
28. Oncogenic role of Pax5 in the T-lymphoid lineage upon ectopic expression from the immunoglobulin heavy-chain locus
    Abdallah Souabni, Wolfram Jochum, Meinrad Busslinger · 2006 · Blood
29. Mechanisms of action of BCL6 during germinal center B cell development
    Chuanxin Huang, Ari M. Melnick · 2015 · Science China Life Sciences
30. miR-28 regulates the germinal center reaction and blocks tumor growth in preclinical models of non-Hodgkin lymphoma
    Nahikari Bartolomé‐Izquierdo, Virginia G. de Yébenes, Ángel F. Álvarez-Prado, Sonia M. Mur, Juan Antonio López, Sergio Roa, Jesús Vázquez, Almudena R. Ramiro · 2017 · Blood
31. Somatic stem cells and the origin of cancer
    Jose Angel Martinez-Climent, Enrique José Andreu, Felipe Prósper · 2006 · Clinical & Translational Oncology
32. FBXO11 inactivation leads to abnormal germinal-center formation and lymphoproliferative disease
    Christof Schneider, Ning Kon, Letizia Amadori, Qiong “John” Shen, Friederike H. Schwartz, Benjamin Tischler, Marion Bossennec, David Dominguez-Sola, Govind Bhagat, Wei Jun Gu et al. · 2016 · Blood
33. The Amount of BCL6 in B Cells Shortly after Antigen Engagement Determines Their Representation in Subsequent Germinal Centers
    Marcus J Robinson, Zhoujie Ding, Catherine Pitt, Erica J. Brodie, Isaak Quast, David Mathew Tarlinton, Dimitra Zotos · 2020 · Cell Reports
34. TCL1A expression delineates biological and clinical variability in B-cell lymphoma
    Mohit Aggarwal, Raquel Villuendas, Gonzalo Goméz-López, Socorro Marıá Rodríguez-Pinilla, Margarita Sánchez‐Beato, David Alvarez, Nerea Martı́nez, Antonia Rodríguez, Maria Esther Castillo, Francisca Inmaculada Camacho et al. · 2008 · Modern Pathology
35. BCL6 is regulated by p53 through a response element frequently disrupted in B-cell non-Hodgkin lymphoma
    Ofer Margalit, Hila Wiener Amram, Ninette Amariglio, Amos J. Simon, Sigal Shaklai, Galit Granot, Neri Minsky, Avichai Shimoni, Alon Harmelin, David Givol et al. · 2005 · Blood
36. UCH-L1 bypasses mTOR to promote protein biosynthesis and is required for MYC-driven lymphomagenesis in mice
    Sajjad Hussain, Tibor Bedekovics, Qiuying Liu, Wenqian Hu, Haeseung Jeon, Sarah H. Johnson, George Vasmatzis, Danielle G. May, Kyle J. Roux, Paul J. Galardy · 2018 · Blood
37. Frequency ofBCL2andBCL6translocations in follicular lymphoma: Relation with histological and clinical features
    Andrea Díaz-Alderete, Angela Alvárez Doval, Francisca Inmaculada Camacho, L. Sanchez Verde, Pilar Sabin, Reyes Arranz-Sáez, Carmen Bellas, Carlos Corbacho, Juana Gil, María Perez-Martín et al. · 2008 · Leukemia & lymphoma/Leukemia and lymphoma
38. HVEM network signaling in cancer
    John R. Šedý, Parham Ramezani-Rad · 2019 · Advances in cancer research
39. B cell lymphoma and myeloma in murine Gaucher's disease
    Elena Pavlova, SZ Wang, Joy Archer, Nick Dekker, Johannes M. F. G. Aerts, Stefan Karlsson, TM Cox · 2013 · The Journal of Pathology
40. UCH-L1 is induced in germinal center B cells and identifies patients with aggressive germinal center diffuse large B-cell lymphoma
    Tibor Bedekovics, Sajjad Hussain, Andrew L. Feldman, Paul J. Galardy · 2015 · Blood
41. Rationally Designed Covalent BCL6 Inhibitor That Targets a Tyrosine Residue in the Homodimer Interface
    Mingxing Teng, Scott B. Ficarro, Hojong Yoon, Jianwei Che, Jing Zhou, Eric S. Fischer, Jarrod A. Marto, Tinghu Zhang, Nathanael S. Gray · 2020 · ACS Medicinal Chemistry Letters
42. Frequent mutations in the amino-terminal domain of BCL7A impair its tumor suppressor role in DLBCL
    Carlos Baliñas-Gavira, María Isabel Rodríguez, Álvaro Andrades, Marta Cuadros, Juan Carlos Álvarez-Pérez, Ángel F. Álvarez-Prado, Virginia G. de Yébenes, Sabina Sánchez-Hernández, Elvira Fernández-Vigo, Javier Muñoz et al. · 2020 · Leukemia
43. BCL6 confers KRAS-mutant non–small-cell lung cancer resistance to BET inhibitors
    Jiawei Guo, Yanan Liu, Jing Lv, Bin Zou, Zhi Chen, Kun Li, Juanjuan Feng, Zhenyu Cai, Lai Wei, Mingyao Liu et al. · 2021 · Journal of Clinical Investigation
44. Therapeutic targeting of the BCL6 oncogene for diffuse large B-cell lymphomas
    Samir Sunil Parekh, Gilbert G. Privé, Ari M. Melnick · 2008 · Leukemia & lymphoma/Leukemia and lymphoma
45. BCL6-mediated Attenuation of DNA Damage Sensing Triggers Growth Arrest and Senescence through a p53-dependent Pathway in a Cell Context-dependent Manner
    Stella Maris Ranuncolo, Wang Ling, Jose Maria Polo, Tania Dell’Oso, Jamil K. Dierov, Terry J. Gaymes, Feyruz Virgilia Rassool, Martin P Carroll, Ari M. Melnick · 2008 · Journal of Biological Chemistry
46. t(14;18)-negative follicular lymphomas are associated with a high frequency of BCL6 rearrangement at the alternative breakpoint region
    Keni Gu, Kai Fu, Smrati Jain, Zhongfen Liu, Javeed Iqbal, Min Li, Warren G. Sanger, Dennis D. Weisenburger, Timothy C. Greiner, Patricia A. Aoun et al. · 2009 · Modern Pathology
47. RHO Family GTPases in the Biology of Lymphoma
    Claudia Voena, Roberto Chiarle · 2019 · Cells
48. Characterization of Bcor expression in mouse development
    Joseph A. Wamstad, Vivian J. Bardwell · 2007 · Gene Expression Patterns
49. Reversible disruption of BCL6 repression complexes by CD40 signaling in normal and malignant B cells
    Jose Maria Polo, Weimin Ci, Jonathan D. Licht, Ari M. Melnick · 2008 · Blood
50. Deregulated expression of HDAC9 in B-cells promotes development of lymphoproliferative disease and lymphoma
    Veronica Gil, Govind Bhagat, L. Howell, Jing Zhang, Chong Kim, Sven Stengel, Francisco Vega, Arthur Zelent, Kevin R. Petrie · 2016 · Disease Models & Mechanisms
51. Smc3 dosage regulates B cell transit through germinal centers and restricts their malignant transformation
    Martín A. Rivas, Cem Meydan, Christopher R. Chin, Matt F. Challman, Daleum Kim, Bhavneet Bhinder, Andreas Kloetgen, Aaron D. Viny, Matt R. Teater, Dylan R. McNally et al. · 2021 · Nature Immunology
52. Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression
    Takami Sato, T. H. Tran, Amy R. Peck, Melanie A. Girondo, C Liu, Chelain R. Goodman, Lynn M. Neilson, Boris Freydin, Inna Chervoneva, Terry Hyslop et al. · 2013 · Oncogene
53. The LRF transcription factor regulates mature B cell development and the germinal center response in mice
    Nagisa Sakurai, Manami Maeda, Sung-Uk Lee, Yuichi Ishikawa, Min Li, John C. Williams, Lisheng Wang, Leila Su, Mai Suzuki, Toshiki I. Saito et al. · 2011 · Journal of Clinical Investigation
54. Epigenetic Function of Activation-Induced Cytidine Deaminase and Its Link to Lymphomagenesis
    Pilar M. Domínguez, Rita Shaknovich · 2014 · Frontiers in Immunology
55. Association of Ig/BCL6 translocations with germinal center B lymphocytes in human lymphoid tissues: implications for malignant transformation
    Xuwei Yang, Koutetsu Lee, JONATHAN W. SAID, Xun Gong, Ke Zhang · 2006 · Blood
56. Differentiation of Rodent Immune and Hematopoietic System Reactive Lesions from Neoplasias
    Jerrold Michael Ward, Jerold E. Rehg, Herbert C. Morse · 2012 · Toxicologic Pathology
57. STAT6-mediated BCL6 repression in primary mediastinal B-cell lymphoma (PMBL)
    Olga Ritz, Karolin Rommel, Karola Dorsch, Elena Kelsch, Julia Melzner, Michaela Buck, Karen Leroy, Vasiliki Papadopoulou, Simon D. Wagner, Ralf B. Marienfeld et al. · 2013 · Oncotarget
58. PDCD2, a protein whose expression is repressed by BCL6, induces apoptosis in human cells by activation of the caspase cascade
    Beverly W. Baron, Elizabeth M. Hyjek, Betty Gladstone, Michael J. Thirman, Joseph M. Baron · 2010 · Blood Cells Molecules and Diseases
59. CD40 Pathway Activation Status Predicts Response to CD40 Therapy in Diffuse Large B Cell Lymphoma
    Bart E. Burington, Yue Peng, Xiaoyan Shi, Ranjana H. Advani, Jeffrey Lau, Jenille Tan, Susanna Y. Stinson, Jeremy Stinson, Thomas Januario, Sven de Vos et al. · 2011 · Science Translational Medicine
60. Bhlhe40 function in activated B and TFH cells restrains the GC reaction and prevents lymphomagenesis
    René Rauschmeier, Annika Reinhardt, Charlotte Gustafsson, Vassilis Glaros, Artem V. Artemov, Josefine Dunst, Reshma Taneja, Igor I. Adameyko, Robert Månsson, Meinrad Busslinger et al. · 2021 · The Journal of Experimental Medicine
61. BACH2–BCL6 balance regulates selection at the pre-B cell receptor checkpoint
    Srividya Swaminathan, Cihangir Duy, Markus Müschen · 2013 · Trends in Immunology
62. Inducible knock-out of BCL6 in lymphoma cells results in tumor stasis
    Schlager, Stefanie, Salomon, Carina, Olt, Sabine, Albrecht, Christoph, Ebert, Anja, Bergner, Oliver, Wachter, Johannes, Trapani, Francesca, Gerlach, Daniel, Voss, Tilman et al. · 2020 · Oncotarget
63. Distinct Apoptotic Signaling Characteristics of the Anti-CD40 Monoclonal Antibody Dacetuzumab and Rituximab Produce Enhanced Antitumor Activity in Non-Hodgkin Lymphoma
    Timothy S. Lewis, Renée S. McCormick, Kim K. Emmerton, Jeffrey Lau, Shang‐Fan Yu, Julie A. McEarchern, Iqbal S. Grewal, Che‐Leung Law · 2011 · Clinical Cancer Research
64. BCL6 Represses Smad Signaling in Transforming Growth Factor-β Resistance
    Degang Wang, Jianyin Long, Fangyan Dai, Min Liang, Xin‐Hua Feng, Xia Lin · 2008 · Cancer Research
65. The Transcription Factor ASCIZ and Its Target DYNLL1 Are Essential for the Development and Expansion of MYC-Driven B Cell Lymphoma
    David M. Wong, Lingli Li, Sabine Jurado, Ashleigh King, Rebecca Bamford, Meaghan Wall, Mannu Walia, Gemma L. Kelly, Carl R. Walkley, David Mathew Tarlinton et al. · 2016 · Cell Reports
66. Pan-SRC kinase inhibition blocks B-cell receptor oncogenic signaling in non-Hodgkin lymphoma
    Elena Battistello, Natalya Katanayeva, Elie Dheilly, Daniele Tavernari, Maria Donaldson Collier, Luca Bonsignore, Margot Thome, Amanda L. Christie, Mark Alan Murakami, Olivier Alain Michielin et al. · 2018 · Blood
67. Germinal centers
    Mark Jay Shlomchik, Florian J. Weisel · 2012 · Immunological Reviews
68. H3K9me3-mediated epigenetic regulation of senescence in mice predicts outcome of lymphoma patients
    Kolja Schleich, Julia Kase, Jan R. Dörr, Saskia Trescher, Animesh Bhattacharya, Yong Yu, Elizabeth M. Wailes, Dorothy Ngo-Yin Fan, Philipp Lohneis, Maja Milanovic et al. · 2020 · Nature Communications
69. Repression of the PDCD2 gene by BCL6 and the implications for the pathogenesis of human B and T cell lymphomas
    Beverly W. Baron, Nancy J. Zeleznik‐Le, Miriam J. Baron, Catherine M. Theisler, Dezheng Huo, Matthew D. Krasowski, Michael J. Thirman, Rebecca Marlene Baron, Joseph M. Baron · 2007 · Proceedings of the National Academy of Sciences
70. The Drosophila BCL6 homolog ken and barbie promotes somatic stem cell self-renewal in the testis niche
    Melanie Issigonis, Erika L. Matunis · 2012 · Developmental Biology
71. Suppression of BCL6 function by HDAC inhibitor mediated acetylation and chromatin modification enhances BET inhibitor effects in B-cell lymphoma cells
    María G. Cortiguera, Lorena García-Gaipo, Simon D. Wagner, Javier León, Ana Batlle‐López, M. Dolores Delgado · 2019 · Scientific Reports
72. LMO 2 and BCL 6 are associated with improved survival in primary central nervous system lymphoma
    Chen Lossos, Soley Bayraktar, Elizabeth P. Weinzierl, Sheren Fouad Younes, Peter J. Hosein, Robert John Tibshirani, Jocelyn S Posthumus, Lisa Marie DeAngelis, Jeffrey J. Raizer, David Schiff et al. · 2014 · British Journal of Haematology
73. Detection of somatic quantitative genetic alterations by multiplex polymerase chain reaction for the prediction of outcome in diffuse large B-cell lymphomas
    Fabrice Jardin, Philippe Ruminy, Jean Pierre Kerckaert, Françoise Parmentier, Jean‐Michel Picquenot, Sabine Quief, Céline Villenet, Gérard Buchonnet, Mario Tosi, Thierry Frébourg et al. · 2008 · Haematologica
74. BLMP-1/Blimp-1 Regulates the Spatiotemporal Cell Migration Pattern in C. elegans
    Tsai-Fang Huang, Chun-Yi Cho, Yi-Ting Cheng, Jheng-Wei Huang, Yunzhe Wu, Athena Yi-Chun Yeh, Kiyoji Nishiwaki, Shih‐Chung Chang, Yi‐Chun Wu · 2014 · PLoS Genetics
75. Resveratrol induces apoptosis in transformed follicular lymphoma OCI-LY8 cells: Evidence for a novel mechanism involving inhibition of BCL6 signaling
    Anthony C. Faber, Thomas C. Chiles · 2006 · International Journal of Oncology
76. NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biological Considerations of Hematological Relapse following Allogeneic Stem Cell Transplantation Unrelated to Graft-versus-Tumor Effects: State of the Science
    Mitchell Stuart Cairo, Craig T. Jordan, Carlo C. Maley, C. Chao, Ari M. Melnick, Scott A. Armstrong, Warren D. Shlomchik, Jeff Molldrem, Soldano Ferrone, Crystal Lee Mackall et al. · 2010 · Transplantation and Cellular Therapy
77. c-Myc overexpression promotes a germinal center-like program in Burkitt's lymphoma
    Henrik Vibe Scheller, Stephanie Tobollik, André Kutzera, Maxwell D. Eder, J Unterlehberg, Ines Pfeil, Berit Jungnickel · 2009 · Oncogene
78. Anomalous constitutive Src kinase activity promotes B lymphoma survival and growth
    Jiyuan Ke, R. Lakshman Chelvarajan, Vishal J. Sindhava, Darrell A. Robertson, Lazaros J. Lekakis, C. DARRELL JENNINGS, Subbarao Bondada · 2009 · Molecular Cancer
79. B Cell Lymphoma 6 (BCL6): A Conserved Regulator of Immunity and Beyond
    Clifford Liongue, Farooq L. J. Almohaisen, Alister C. Ward · 2024 · International Journal of Molecular Sciences
80. AID-associated DNA repair pathways regulate malignant transformation in a murine model of BCL6-driven diffuse large B-cell lymphoma
    Xiwen Gu, Carmen Jane Booth, Zongzhi Z. Liu, Matthew P. Strout · 2015 · Blood
81. Sequential Transcription Factor Targeting for Diffuse Large B-Cell Lymphomas
    Leandro C. A. Cerchietti, Jose Maria Polo, Gustavo Felippe da Silva, Pedro Farinha, Rita Shaknovich, Randy D. Gascoyne, Steven F. Dowdy, Ari M. Melnick · 2008 · Cancer Research
82. The BCL6‐associated transcriptional co‐repressor, MTA3, is selectively expressed by germinal centre B cells and lymphomas of putative germinal centre derivation
    David L. Jaye, Javeed Iqbal, N Fujita, Cissy Geigerman, Shiyong Li, Suresh Karanam, Kai Fu, Dennis D Weisenburger, WC Chan, Carlos S. Moreno et al. · 2007 · The Journal of Pathology
83. Discovery of novel BCL6-Targeting PROTACs with effective antitumor activities against DLBCL in vitro and in vivo
    Dazhao Mi, Li Cheng, Yuzhan Li, Mingyue Yao, Yan Li, Keyu Hong, Chengying Xie, Yihua Chen · 2024 · European Journal of Medicinal Chemistry
84. B-cell Lymphoma 6 Inhibitors: Current Advances and Prospects of Drug Development for Diffuse Large B-cell Lymphomas
    Haijun Gu, Jia He, Yuzhan Li, Dazhao Mi, Tian Guan, Weikai Guo, Bo Liu, Yihua Chen · 2022 · Journal of Medicinal Chemistry
85. Concurrent inhibition of MYC and BCL2 is a potentially effective treatment strategy for double hit and triple hit B-cell lymphomas
    Munevver Cinar, FRED P. ROSENFELT, Sepehr Rokhsar, Jean Raphael Lopategui, Raju K. Pillai, Melissa Cervania, Andy Pao, Bekir Cinar, Serhan Alkan · 2015 · Leukemia Research
86. An orally available small molecule BCL6 inhibitor effectively suppresses diffuse large B cell lymphoma cells growth in vitro and in vivo
    Yajing Xing, Weikai Guo, Min Yi Wu, Jiuqing Xie, Dongxia Huang, Pan Hu, Miaoran Zhou, Lin Zhang, Qiansen Zhang, Peili Wang et al. · 2022 · Cancer Letters
87. Pathogenesis of diffuse large B cell lymphoma
    Wing Chung Chan · 2010 · International Journal of Hematology
88. The Novel IKK2 Inhibitor LY2409881 Potently Synergizes with Histone Deacetylase Inhibitors in Preclinical Models of Lymphoma through the Downregulation of NF-κB
    Changchun Deng, Mark R. Lipstein, Richard Rodriguez, Xavier O. Jirau Serrano, Christine M. Mcintosh, Wei‐Yann Tsai, Andrew S. Wasmuth, Susan Jaken, Owen A. O’Connor · 2014 · Clinical Cancer Research
89. Specific peptides for the therapeutic targeting of oncogenes
    Gilbert G. Privé, Ari M. Melnick · 2005 · Current Opinion in Genetics & Development
90. A Synchronous IRF4-Dependent Gene Regulatory Network in B and Helper T Cells Orchestrating the Antibody Response
    Sarah L. Cook, Marissa C. Franke, Evelyn P. Sievert, Roger Sciammas · 2020 · Trends in Immunology
91. TBL1X: At the crossroads of transcriptional and posttranscriptional regulation
    Betsy A. Pray, Youssef Youssef, Lapo Alinari · 2022 · Experimental Hematology
92. PIM1 gene cooperates with human BCL6 gene to promote the development of lymphomas
    Beverly W. Baron, John Anastasi, Elizabeth M. Hyjek, Juraj Bies, Poluru L. Reddy, Jingfang Dong, Loren J. Joseph, Michael J. Thirman, Kristen Wroblewski, Linda Wolff et al. · 2012 · Proceedings of the National Academy of Sciences
93. SEMMs: Somatically Engineered Mouse Models. A New Tool for In Vivo Disease Modeling for Basic and Translational Research
    Anthony Lima, Danilo Maddalo · 2021 · Frontiers in Oncology
94. Targeting Epigenetic protein–protein Interactions With small-molecule Inhibitors
    Brian M. Linhares, Jolanta E. Grembecka, Tomasz Cierpicki · 2020 · Future Medicinal Chemistry
95. The Role of RhoH in TCR Signalling and Its Involvement in Diseases
    Ahmad Mokhtar, Ana Masara, Hashim, Ilie Fadzilah, Mohd Zaini Makhtar, Muaz, Salikin, Nor Hawani, Amin-Nordin, Syafinaz · 2021 · Cells
96. Molecular classification and therapeutics in diffuse large B-cell lymphoma
    Gaelen Shimkus, T. NONAKA · 2023 · Frontiers in Molecular Biosciences
97. Gammaherpesviruses and B Cells: A Relationship That Lasts a Lifetime
    Kaitlin E. Johnson, Vera L. Tarakanova · 2020 · Viral Immunology
98. Dysregulation of miRNAs in DLBCL: Causative Factor for Pathogenesis, Diagnosis and Prognosis
    Mohammed Alsaadi, Muhammad Yasir Khan, Mahmood Hassan Dalhat, Salem Bahashwan, Muhammad Uzair Khan, Abdulgader H. Albar, Hussein A. Almehdar, Ishtiaq Qadri · 2021 · Diagnostics
99. Gene Interaction Network Regulates Plasma Cell Differentiation
    Jukka Alinikula, Olli Lassila · 2011 · Scandinavian Journal of Immunology
100. Rewired NFκB signaling as a potentially actionable feature of activated B‐cell‐like diffuse large B‐cell lymphoma
     Gero Knittel, Paul Liedgens, Darya Korovkina, Christian Philipp Pallasch, Hans Christian Reinhardt · 2016 · European Journal Of Haematology